News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
42,385 Results
Type
Article (2757)
Company Profile (40)
Press Release (39588)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14946)
Career Advice (78)
Deals (2258)
Drug Delivery (9)
Drug Development (4793)
Employer Resources (10)
FDA (610)
Job Trends (877)
News (22109)
Policy (1314)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (165)
Allergies (8)
Alliances (3735)
ALS (4)
Alzheimer's disease (46)
Antibody-drug conjugate (ADC) (18)
Approvals (614)
Artificial intelligence (12)
Autoimmune disease (3)
Automation (1)
Bankruptcy (14)
Best Places to Work (584)
BIOSECURE Act (2)
Biosimilars (15)
Biotechnology (30)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (22)
Cancer (151)
Cardiovascular disease (9)
Career advice (65)
Career pathing (1)
CAR-T (16)
Cell therapy (47)
Cervical cancer (2)
Clinical research (3808)
Collaboration (96)
Compensation (51)
COVID-19 (193)
CRISPR (7)
C-suite (32)
Cystic fibrosis (2)
Data (143)
Denatured (3)
Depression (3)
Diabetes (11)
Diagnostics (480)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (7)
Duchenne muscular dystrophy (17)
Earnings (4546)
Editorial (4)
Employer branding (1)
Employer resources (8)
Events (6490)
Executive appointments (98)
FDA (668)
Featured Employer (4)
Funding (84)
Gene editing (14)
Gene therapy (23)
GLP-1 (63)
Government (181)
Healthcare (819)
Huntington's disease (3)
IgA nephropathy (4)
Immunology and inflammation (16)
Indications (3)
Infectious disease (198)
Inflammatory bowel disease (12)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (1064)
IRA (7)
Job creations (296)
Job search strategy (63)
Kidney cancer (4)
Labor market (4)
Layoffs (39)
Leadership (1)
Legal (293)
Liver cancer (5)
Lung cancer (15)
Lymphoma (4)
Management (4)
Manufacturing (20)
MASH (4)
Medical device (347)
Medtech (347)
Mergers & acquisitions (1269)
Metabolic disorders (38)
Multiple sclerosis (9)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (93)
NextGen: Class of 2025 (400)
Non-profit (180)
Northern California (384)
Now hiring (4)
Obesity (18)
Opinion (15)
Ovarian cancer (10)
Pain (12)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (2)
Patents (23)
Patient recruitment (6)
Peanut (3)
People (5881)
Pharmaceutical (5)
Phase I (1459)
Phase II (1820)
Phase III (1166)
Pipeline (87)
Policy (12)
Postmarket research (85)
Preclinical (650)
Press Release (2)
Prostate cancer (4)
Psychedelics (2)
Radiopharmaceuticals (13)
Rare diseases (29)
Real estate (436)
Recruiting (5)
Regulatory (980)
Reports (6)
Research institute (155)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (26)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Southern California (377)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (499)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1904)
Vaccines (29)
Venture capitalists (8)
Weight loss (14)
Women's health (2)
Worklife (1)
Date
Today (24)
Last 7 days (79)
Last 30 days (251)
Last 365 days (2765)
2025 (885)
2024 (2833)
2023 (3117)
2022 (4093)
2021 (4383)
2020 (3748)
2019 (2438)
2018 (1803)
2017 (2012)
2016 (1808)
2015 (2044)
2014 (1535)
2013 (1331)
2012 (1537)
2011 (1485)
2010 (1338)
Location
Africa (48)
Alabama (1)
Arizona (15)
Asia (2123)
Australia (326)
California (889)
Canada (152)
China (43)
Colorado (21)
Connecticut (13)
Delaware (4)
Europe (4425)
Florida (49)
Georgia (5)
Idaho (3)
Illinois (21)
India (1)
Indiana (33)
Japan (14)
Kansas (12)
Maryland (29)
Massachusetts (340)
Michigan (9)
Minnesota (15)
Missouri (4)
Nebraska (1)
Nevada (4)
New Hampshire (2)
New Jersey (82)
New Mexico (2)
New York (52)
North Carolina (92)
Northern California (384)
Ohio (26)
Oklahoma (2)
Oregon (5)
Pennsylvania (79)
Rhode Island (2)
South America (46)
South Carolina (1)
Southern California (377)
Tennessee (2)
Texas (74)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (54)
Wisconsin (6)
42,385 Results for "mineral biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
MBX Biosciences Presents Positive Results from Phase 1 Study of MBX 2109 in Late-Breaking Oral Presentation at the American Society for Bone and Mineral Research Annual Meeting
MBX Biosciences, Inc. today announced the presentation of positive results from its Phase 1 single and multiple ascending dose trial of MBX 2109 in healthy adults, as a late-breaking oral presentation at the American Society for Bone and Mineral Research (ASBMR) Annual Meeting, held in Vancouver, Canada from October 13-16, 2023.
October 16, 2023
·
4 min read
Drug Development
MBX Biosciences to Showcase Results from Phase 1 Study of MBX 2109 in Late-Breaking Oral Presentation at the American Society for Bone and Mineral Research Annual Meeting
MBX Biosciences, Inc. today announced that results from the Phase 1 Study of MBX 2109, the company’s long-acting parathyroid hormone (PTH) peptide prodrug in development for the treatment of hypoparathyroidism (HP), will be featured in a late-breaking oral presentation at the American Society for Bone and Mineral Research (ASBMR) Annual Meeting being held in Vancouver, Canada October 13-16, 2023.
October 3, 2023
·
3 min read
Layoffs
IGM Biosciences Lays Off 73% of Staff, Shrinks Pipeline
Staff cuts will leave IGM Biosciences with 37 employees. The company is also halting development of two bispecific antibody T cell engagers for autoimmune diseases.
January 10, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Harvard Bioscience Announces CFO Transition
April 11, 2025
·
3 min read
Press Releases
Chromatin Bioscience Signs Collaboration Agreement with Astellas
April 14, 2025
·
2 min read
Press Releases
Octave Bioscience’s MSDA Test Proven to Provide Clinically Actionable Insights That Drive Meaningful Clinical Decisions in MS Care
April 17, 2025
·
4 min read
Press Releases
Inozyme Pharma Presents New Data at the American Society for Bone and Mineral Research (ASBMR) 2024 Annual Meeting
September 27, 2024
·
11 min read
Press Releases
Keymed Biosciences Announces Annual Results of 2024
March 27, 2025
·
12 min read
Press Releases
Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors
April 2, 2025
·
5 min read
Drug Development
Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research
Entera Bio Ltd. announced today that data from the Phase 2 Trial of its lead clinical compound, EB613 (Oral PTH(1-34) Tablets) for the Treatment of Post-Menopausal Women with Low BMD or Osteoporosis compared to placebo were published in the Journal of Bone and Mineral Research (JBMR).
April 8, 2024
·
6 min read
1 of 4,239
Next
